Aarey Drugs & Pharmaceuticals Limited
NSE: AAREYDRUGS
NSE
52.21
-0.82 (-1.55%)
Prev Close
53.03
Open Price
52.99
Volume
9,437
Today Low / High
50.75 / 52.99
52 WK Low / High
32.85 / 74.8
Range
50 - 55
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 52.21, with a change of -0.82 (-1.54629%). The expected target range on the NSE is between 50 - 55. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
09 May
52.99
-1.47%
08 May
53.75
-1.34%
07 May
51.09
3.41%
06 May
53.23
-0.96%
05 May
53.86
-1.17%
02 May
52.65
0.97%
30 Apr
53.59
0.11%
29 Apr
55.25
-3.00%
28 Apr
56.35
-2.93%
25 Apr
57.51
-2.85%
24 Apr
58.03
1.02%
23 Apr
58.01
1.40%
22 Apr
57.98
-0.12%
21 Apr
57.77
-0.68%
17 Apr
57.99
-3.33%
16 Apr
55.05
0.33%
15 Apr
50.70
3.75%
11 Apr
47.44
6.07%
Aarey Drugs & Pharmaceuticals Limited Graph
Aarey Drugs & Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Aarey Drugs & Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 52.21, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 52.21 | 52.73 | 47.46 - 58.01 |
| 53.25 | 42.60 - 63.91 | ||
| 53.78 | 37.64 - 69.91 | ||
| Bearish Scenario | 52.21 | 51.69 | 46.52 - 56.86 |
| 51.17 | 40.93 - 61.40 | ||
| 50.64 | 35.45 - 65.84 |
Overview of Aarey Drugs & Pharmaceuticals Limited
ISIN
INE198H01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
61,638
Market Cap
1,480,378,003
Last Dividend
0
Official Website
IPO Date
2021-08-06
DCF Diff
77.97
DCF
-25
Financial Ratios Every Investor Needs
Stock Dividend of AAREYDRUGS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2018-12-13 | December 13, 18 | 0.1 | 0.1 | 2018-12-14 | 2018-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 395.10 Cr | 381.90 Cr | 13.20 Cr | 0.0334 | 0.00 Cr | 0.42 Cr | 2.82 Cr | 4.68 Cr | 1.84 | 11.42 Cr | 0.0119 |
| 2023-03-31 | 414.25 Cr | 403.84 Cr | 10.41 Cr | 0.0251 | 0.00 Cr | 0.88 Cr | 6.69 Cr | 3.77 Cr | 1.49 | 8.27 Cr | 0.0091 |
| 2022-03-31 | 491.61 Cr | 472.06 Cr | 19.54 Cr | 0.0398 | 0.00 Cr | 0.61 Cr | 10.03 Cr | 6.55 Cr | 2.72 | 12.01 Cr | 0.0133 |
| 2021-03-31 | 347.89 Cr | 337.79 Cr | 10.10 Cr | 0.0290 | 0.00 Cr | 0.32 Cr | 8.23 Cr | 6.51 Cr | 2.79 | 9.15 Cr | 0.0187 |
| 2020-03-31 | 300.09 Cr | 290.18 Cr | 9.91 Cr | 0.0330 | 0.00 Cr | 0.43 Cr | 6.35 Cr | 5.79 Cr | 2.48 | 7.25 Cr | 0.0193 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 1.59 Cr | 303.29 Cr | 170.52 Cr | 132.7734 Cr | 31.35 Cr | 29.76 Cr | 71.99 Cr | 12.96 Cr | 0.00 Cr | 0.00 Cr | 2.09 Cr | 166.5469 Cr |
| 2023-03-31 | 0.71 Cr | 291.32 Cr | 173.91 Cr | 117.4138 Cr | 37.72 Cr | 37.01 Cr | 28.82 Cr | 13.94 Cr | 5.28 Cr | 0.00 Cr | 0.41 Cr | 168.1349 Cr |
| 2022-03-31 | 0.19 Cr | 245.17 Cr | 131.53 Cr | 113.6373 Cr | 14.16 Cr | 13.97 Cr | 13.68 Cr | 14.47 Cr | 5.23 Cr | -3.34 Cr | 2.80 Cr | 130.0762 Cr |
| 2021-03-31 | 0.64 Cr | 233.04 Cr | 134.18 Cr | 98.8605 Cr | 18.02 Cr | 17.38 Cr | 18.46 Cr | 14.26 Cr | 4.25 Cr | 0.00 Cr | 0.40 Cr | 132.6120 Cr |
| 2020-03-31 | 0.49 Cr | 194.08 Cr | 101.74 Cr | 92.3462 Cr | 17.89 Cr | 17.40 Cr | 17.00 Cr | 12.34 Cr | 4.64 Cr | 0.00 Cr | 0.40 Cr | 100.2778 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -2.9938 Cr | -1.7023 Cr | 5.5848 Cr | -3.7161 Cr | 0.8886 Cr | 1.5944 Cr | -0.7223 Cr | 4.6837 Cr | -1.1362 Cr | 0.0000 Cr | -5.8566 Cr |
| 2023-03-31 | -1.2811 Cr | 0.4410 Cr | 1.3540 Cr | -2.3251 Cr | 0.5139 Cr | 0.7058 Cr | -1.0440 Cr | 6.0151 Cr | 4.2211 Cr | 0.0000 Cr | -15.1352 Cr |
| 2022-03-31 | -4.4930 Cr | -2.1967 Cr | 6.2319 Cr | -6.6943 Cr | -0.4578 Cr | 0.1919 Cr | -2.2013 Cr | 10.0271 Cr | 0.0000 Cr | 0.0000 Cr | 4.7767 Cr |
| 2021-03-31 | 5.4770 Cr | -2.8793 Cr | -2.4507 Cr | 2.5977 Cr | 0.1470 Cr | 0.6497 Cr | -2.8793 Cr | 8.3014 Cr | -0.0191 Cr | 0.0000 Cr | -1.4646 Cr |
| 2020-03-31 | 2.8572 Cr | -0.9186 Cr | -1.8047 Cr | 1.9386 Cr | 0.1340 Cr | 0.5027 Cr | -0.9186 Cr | 7.2424 Cr | -0.0195 Cr | 0.0000 Cr | 4.2543 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 133.79 Cr | 130.39 Cr | 3.40 Cr | 0.0254 | 1.62 Cr | 0.72 Cr | 0.26 | 2.88 Cr | 0.0054 |
| 2024-09-30 | 105.14 Cr | 98.90 Cr | 6.24 Cr | 0.0594 | 3.23 Cr | 1.60 Cr | 0.57 | 3.74 Cr | 0.0152 |
| 2024-06-30 | 126.91 Cr | 123.59 Cr | 3.32 Cr | 0.0261 | 2.58 Cr | 1.24 Cr | 0.44 | 2.75 Cr | 0.0098 |
| 2024-03-31 | 210.35 Cr | 206.75 Cr | 3.60 Cr | 0.0171 | -1.84 Cr | 2.15 Cr | 0.77 | 3.70 Cr | 0.0102 |
| 2023-12-31 | 76.48 Cr | 73.34 Cr | 3.14 Cr | 0.0410 | 2.23 Cr | 1.91 Cr | 0.75 | 3.00 Cr | 0.0249 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 1.49 Cr | 0.00 Cr | 1.49 Cr | 0.00 Cr | 29.84 Cr | 251.35 Cr | 12.99 Cr | 274.53 Cr | 138.94 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | 2.89 Cr | 0.00 Cr | 0.00 Cr | -132.77 Cr |
| 2024-03-31 | 1.59 Cr | 1.30 Cr | 1.59 Cr | 200.85 Cr | 34.68 Cr | 282.60 Cr | 14.66 Cr | 304.99 Cr | 172.22 Cr |
| 2023-12-31 | -7.46 Cr | 14.91 Cr | 7.46 Cr | 0.00 Cr | 0.00 Cr | 7.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 1.17 Cr | 6.29 Cr | 7.46 Cr | 109.54 Cr | 22.37 Cr | 217.98 Cr | 13.23 Cr | 233.99 Cr | 115.07 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 1.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 2.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 1.02 Cr | 0.94 Cr | 0.00 Cr | 0.00 Cr | 0.94 Cr | 2.11 Cr | 1.17 Cr | 0.00 Cr | 0.94 Cr |
| 2023-09-30 | 0.78 Cr | 0.82 Cr | 0.00 Cr | 0.00 Cr | 0.82 Cr | 1.17 Cr | 0.35 Cr | 0.00 Cr | 0.82 Cr |
| 2023-06-30 | 0.72 Cr | 0.83 Cr | 0.00 Cr | 0.00 Cr | 0.83 Cr | 1.54 Cr | 0.71 Cr | 0.00 Cr | 0.83 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,733.60 | ₹4,159,391,808,000.00 | ₹404,107.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹5,948.50 | ₹1,579,142,346,500.00 | ₹211,514.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,116.20 | ₹1,054,662,309,000.00 | ₹258,298.00 |
| Mankind Pharma Limited | MANKIND | ₹2,388.90 | ₹985,608,826,428.00 | ₹96,433.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,145.00 | ₹953,914,407,900.00 | ₹681,250.00 |
| Lupin Limited | LUPIN | ₹2,015.90 | ₹920,494,210,300.00 | ₹308,168.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹872.30 | ₹877,734,429,000.00 | ₹409,498.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,146.10 | ₹665,657,172,200.00 | ₹305,690.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,879.50 | ₹583,417,417,500.00 | ₹24,065.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,402.60 | ₹395,815,122,600.00 | ₹213,490.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,342.10 | ₹340,496,138,400.00 | ₹82,605.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,522.10 | ₹315,040,555,200.00 | ₹28,056.00 |
| Laurus Labs Limited | LAURUSLABS | ₹583.00 | ₹314,384,499,000.00 | ₹920,366.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,068.80 | ₹272,079,072,000.00 | ₹94,167.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,523.00 | ₹237,096,071,000.00 | ₹86,963.00 |
| Piramal Enterprises Limited | PEL | ₹1,004.15 | ₹226,413,733,700.00 | ₹435,455.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,040.50 | ₹201,012,500,000.00 | ₹8,639.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,229.80 | ₹199,816,674,200.00 | ₹273,019.00 |
| Eris Lifesciences Limited | ERIS | ₹1,446.50 | ₹196,991,602,500.00 | ₹85,897.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹883.00 | ₹173,565,129,000.00 | ₹53,549.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,119.00 | ₹155,485,558,100.00 | ₹23,464.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹795.05 | ₹142,401,405,500.00 | ₹243,623.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,855.20 | ₹141,016,905,840.00 | ₹35,452.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹862.45 | ₹137,371,898,450.00 | ₹96,883.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹436.40 | ₹105,846,201,600.00 | ₹1,017,816.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,996.50 | ₹82,938,902,100.00 | ₹3,340.00 |
| FDC Limited | FDC | ₹426.15 | ₹69,381,481,500.00 | ₹57,995.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹734.10 | ₹66,534,874,542.00 | ₹173,562.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹633.15 | ₹61,916,308,335.00 | ₹91,066.00 |
| Strides Pharma Science Limited | STAR | ₹626.80 | ₹57,767,580,360.00 | ₹86,004.00 |
| Innova Captab Limited | INNOVACAP | ₹843.65 | ₹48,277,812,195.00 | ₹42,284.00 |
| Hikal Limited | HIKAL | ₹378.15 | ₹46,626,273,150.00 | ₹125,761.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹139.25 | ₹45,189,688,500.00 | ₹198,900.00 |
| Sequent Scientific Limited | SEQUENT | ₹157.53 | ₹39,430,074,060.00 | ₹974,546.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹773.85 | ₹39,248,975,535.00 | ₹12,354.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹546.15 | ₹38,452,127,670.00 | ₹24,443.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹406.40 | ₹37,092,128,000.00 | ₹310,597.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹348.15 | ₹34,911,785,700.00 | ₹36,678.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,008.10 | ₹33,211,965,900.00 | ₹6,645.00 |
| Suven Life Sciences Limited | SUVEN | ₹140.50 | ₹30,639,397,000.00 | ₹522,360.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹55.76 | ₹30,553,915,040.00 | ₹5,181,318.00 |
| Alembic Limited | ALEMBICLTD | ₹96.48 | ₹24,774,327,264.00 | ₹167,661.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹502.10 | ₹23,240,952,244.00 | ₹42,576.00 |
| Indoco Remedies Limited | INDOCO | ₹241.20 | ₹22,250,193,480.00 | ₹30,328.00 |
Key Executives
Chief Accountant
Mr. A. S. Kathawala
Gender: male
Year Born: 1976
Company Secretary & Compliance Officer
Mr. Kailash Chand Jethlia
Gender: male
Year Born:
Chairman & MD
Mr. Mihir Rajesh Ghatalia B.E
Gender: male
Year Born: 1983
Chief Financial Officer
Ms. Mira Mihir Ghatalia
Gender: female
Year Born:
Executive Director
Mr. Nimit Rajesh Ghatalia
Gender: male
Year Born: 1996
FAQs about Aarey Drugs & Pharmaceuticals Limited
Who is the CEO of the company?
The CEO is Mr. Mihir Rajesh Ghatalia B.E.
What is the current market price of the stock?
The current price is ₹52.21.
What is the 52-week price range?
The range is ₹32.85-74.8.
What is the market capitalization of the company?
The market capitalization is ₹148.04 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 25.67.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Aarey Drugs & Pharmaceuticals Limited (ISIN: INE198H01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹148.04 crores and an average daily volume of 61,638 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.